human glioblastoma u87 mg cells (ATCC)
ATCC is a verified supplier 
ATCC manufactures this product 
99
Structured Review
ATCC
human glioblastoma u87 mg cells
Human Glioblastoma U87 Mg Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 10546 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/u87+cells/U-87+MG/pm42278448-476-33-39
Average 99 stars, based on 10546 article reviews
Human Glioblastoma U87 Mg Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 10546 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/u87+cells/U-87+MG/pm42278448-476-33-39
Average 99 stars, based on 10546 article reviews
human glioblastoma u87 mg cells - by Bioz Stars,
2026-09
99/100 stars
Images
Related Articles
Transduction:Article Title: Real-time volumetric imaging of cells and molecules in deep tissues with Takoyaki ultrasound. Article Snippet: .. Infection:Article Title: Real-time volumetric imaging of cells and molecules in deep tissues with Takoyaki ultrasound. Article Snippet: .. Incubation:Article Title: Real-time volumetric imaging of cells and molecules in deep tissues with Takoyaki ultrasound. Article Snippet: .. Stable Transfection:Article Title: Bispecific antibody molecules binding to CD3 and EGFRvIII Article Snippet: .. The EGFRvIII TCB (comprising the optimized CD3 binder identified in Example 1) was likewise tested for its anti-tumoral efficacy in a xenograft mouse model of a human tumor cell line, the U87-EGFRvIII glioblastoma xenograft model. Transfection:Article Title: Bispecific antibody molecules binding to CD3 and EGFRvIII Article Snippet: .. The EGFRvIII TCB (comprising the optimized CD3 binder identified in Example 1) was likewise tested for its anti-tumoral efficacy in a xenograft mouse model of a human tumor cell line, the U87-EGFRvIII glioblastoma xenograft model. Cell Culture:Article Title: Tunable 3D‐Printed Static Mixers for Gradient Bioprinting With High Cell Viability Article Snippet: .. Functional Assay:Article Title: Restoring the glioblastoma tumor microenvironment by targeting C5a with the antagonist W54011. Article Snippet: .. Lastly, although Article Title: Restoring the glioblastoma tumor microenvironment by targeting C5a with the antagonist W54011 Article Snippet: .. Lastly, although Variant Assay:Article Title: Restoring the glioblastoma tumor microenvironment by targeting C5a with the antagonist W54011. Article Snippet: .. Lastly, although Article Title: Restoring the glioblastoma tumor microenvironment by targeting C5a with the antagonist W54011 Article Snippet: .. Lastly, although Derivative Assay:Article Title: Restoring the glioblastoma tumor microenvironment by targeting C5a with the antagonist W54011. Article Snippet: .. Lastly, although Article Title: Restoring the glioblastoma tumor microenvironment by targeting C5a with the antagonist W54011 Article Snippet: .. Lastly, although Multiple Displacement Amplification:Article Title: OR7A10 GPCR engineering boosts CAR-NK therapy against solid tumours. Article Snippet: Chimeric antigen receptor (CAR)-natural killer (NK) cell therapies hold promise for solid tumours but remain limited because of poor tumour infiltration, persistence and resistance in the tumour microenvironment.. Here, to identify gain-of-function targets that enhance CAR-NK cell efficacy, we performed an unbiased in vivo CRISPR activation screen followed by a barcoded targeted in vivo open reading frame screen in primary human CAR-NK cells.. We identified and comprehensively validated OR7A10, a G protein-coupled receptor (GPCR), as the top candidate. |
